Roche Seen Sealing Genentech, Inc. Deal After Upping Bid

March 9, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

ZURICH (Reuters) - Roche Holding AG (VTX:ROG.VX - News) looks likely to seal a deal to buy out U.S. biotech group Genentech Inc (NYSE:DNA - News), analysts said on Monday, after the Swiss drugmaker upped its offer to $45.7 billion.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe

Genentech, Inc. Roche